Ocular Therapeutix, Inc. (OCUL)

NASDAQ: OCUL · Real-Time Price · USD

12.14

+0.01 (0.08%)

At close: Nov 26, 2025, 4:00 PM EST

12.19

+0.05 (0.41%)

After-hours: Nov 26, 2025, 4:10 PM EST

Ocular Therapeutix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Nov '25 Nov 26, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	2,586	1,343	492	216	534	1,559	Upgrade
Market Cap Growth	49.44%	173.13%	127.16%	-59.47%	-65.74%	720.77%	Upgrade
Enterprise Value	2,319	991	464	155	413	1,546	Upgrade
Last Close Price	12.14	8.54	4.46	2.81	6.97	20.70	Upgrade
PS Ratio	37.77	21.07	8.41	4.20	12.27	89.57	Upgrade
PB Ratio	8.22	4.26	5.39	6.12	6.07	20.48	Upgrade
P/TBV Ratio	10.02	4.26	5.39	6.12	6.07	20.48	Upgrade
EV/Sales Ratio	41.57	15.54	7.94	3.01	9.50	88.85	Upgrade
Debt / Equity Ratio	0.30	0.24	0.92	1.82	0.67	0.77	Upgrade
Asset Turnover	0.12	0.18	0.29	0.29	0.19	0.10	Upgrade
Inventory Turnover	65.67	49.86	31.01	35.98	44.46	28.56	Upgrade
Quick Ratio	7.62	10.27	6.36	3.94	7.04	9.01	Upgrade
Current Ratio	7.85	10.66	6.66	4.13	7.26	9.23	Upgrade
Return on Equity (ROE)	-81.83%	-95.21%	-127.64%	-115.16%	-7.99%	-429.55%	Upgrade
Return on Assets (ROA)	-36.61%	-30.53%	-25.66%	-27.76%	-20.90%	-23.06%	Upgrade
Return on Capital (ROIC)	-43.27%	-38.31%	-37.56%	-39.86%	-34.65%	-41.29%	Upgrade
Return on Capital Employed (ROCE)	-73.00%	-41.60%	-37.90%	-66.70%	-43.70%	-26.70%	Upgrade
Earnings Yield	-9.65%	-14.41%	-16.42%	-32.83%	-1.23%	-9.98%	Upgrade
FCF Yield	-7.71%	-10.13%	-15.53%	-29.26%	-12.50%	-3.49%	Upgrade
Buyback Yield / Dilution	-26.34%	-84.90%	-3.57%	-0.59%	-35.24%	-34.19%	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q